96 phenotypes from 7 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst B6.129P2-Tnip1Gt(E059E05)Wrst	prenatal lethality, incomplete penetrance	J:180054
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst involves: 129P2/OlaHsd * C57BL/6	anemia	J:180054
	cachexia	J:180054
	decreased body size	J:180054
	decreased body weight	J:180054
	decreased hemoglobin content	J:180054
	decreased interleukin-12 secretion	J:180054
	decreased interleukin-12b secretion	J:180054
	enlarged lymph nodes	J:180054
	enlarged spleen	J:180054
	glomerulonephritis	J:180054
	increased anti-double stranded DNA antibody level	J:180054
	increased anti-nuclear antigen antibody level	J:180054
	increased IgA level	J:180054
	increased IgG1 level	J:180054
	increased IgG2b level	J:180054
	increased IgM level	J:180054
	increased neutrophil cell number	J:180054
	increased susceptibility to systemic lupus erythematosus	J:180054
	increased urine protein level	J:180054
	lymph node hyperplasia	J:180054
	premature death	J:180054
	prenatal lethality, incomplete penetrance	J:180054
	spleen hyperplasia	J:180054
Tnip1m1Btlr/Tnip1m1Btlr C57BL/6J-Tnip1m1Btlr	decreased B cell number	J:265175
	decreased B-2 B cell number	J:265175
	increased anti-double stranded DNA antibody level	J:265175
	increased B-1a cell number	J:265175
	increased B-1b cell number	J:265175
	increased dendritic cell number	J:265175
	increased IgA level	J:265175
	increased IgE level	J:265175
	increased macrophage cell number	J:265175
	increased susceptibility to induced colitis	J:265175
Tnip1tm1.1Ama/Tnip1tm1.1Ama involves: C57BL/6J	anemia	J:145539
	decreased fetal size	J:145539
	decreased fetal weight	J:145539
	decreased hematocrit	J:145539
	increased fibroblast apoptosis	J:145539
	increased hepatocyte apoptosis	J:145539
	liver hypoplasia	J:145539
	pallor	J:145539
	perinatal lethality, incomplete penetrance	J:145539
Tnip1tm1.1Pcoh/Tnip1+ involves: 129P2/OlaHsd * C57BL/6	increased anti-double stranded DNA antibody level	J:176826
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh involves: 129P2/OlaHsd * C57BL/6	abnormal blood vessel morphology	J:176826
	abnormal complement pathway	J:176826
	abnormal effector T cell morphology	J:176826
	abnormal immune system morphology	J:176826
	abnormal intestine morphology	J:176826
	abnormal Peyer's patch morphology	J:176826
	abnormal plasma cell morphology	J:176826
	abnormal spleen germinal center morphology	J:176826
	bile duct hyperplasia	J:176826
	enlarged lymph nodes	J:176826
	enlarged spleen	J:176826
	glomerulonephritis	J:176826
	normal immune system phenotype	J:176826
	increased anti-double stranded DNA antibody level	J:176826
	increased anti-nuclear antigen antibody level	J:176826
	increased B cell number	J:176826
	increased B cell proliferation	J:176826
	increased fibroblast apoptosis	J:176826
	increased germinal center B cell number	J:176826
	increased granulocyte number	J:176826
	increased IgA level	J:176826
	increased IgE level	J:176826
	increased IgG1 level	J:176826
	increased IgG2a level	J:176826
	increased IgG2b level	J:176826
	increased IgG3 level	J:176826
	increased IgG level	J:176826
	increased IgM level	J:176826
	increased immunoglobulin level	J:176826
	increased interleukin-6 secretion	J:176826
	increased interleukin-12b secretion	J:176826
	increased monocyte cell number	J:176826
	increased plasma cell number	J:176826
	increased spleen red pulp amount	J:176826
	increased spleen weight	J:176826
	increased spleen white pulp amount	J:176826
	increased T follicular helper cell number	J:176826
	increased tumor necrosis factor secretion	J:176826
	liver fibrosis	J:176826
	premature death	J:176826
	vascular inflammation	J:176826
Tnip1tm1.2Ama/Tnip1tm1.2Ama Tg(Itgax-cre)1-1Reiz/0 involves: C57BL/6 * C57BL/6J * CBA	abnormal hematopoietic stem cell physiology	J:205446
	abnormal leukocyte morphology	J:205446
	enlarged lymph nodes	J:205446
	enlarged spleen	J:205446
	increased interleukin-6 secretion	J:205446
	increased interleukin-12 secretion	J:205446
	increased interleukin-23 secretion	J:205446
	increased memory T cell number	J:205446
	increased plasmacytoid dendritic cell number	J:205446
	increased tumor necrosis factor secretion	J:205446
Tnip1tm1.2Pcoh/Tnip1tm1.2Pcoh involves: 129P2/OlaHsd * C57BL/6	abnormal immune system morphology	J:176826
	premature death	J:176826
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating triglyceride level	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
	increased freezing behavior	J:211773
	increased large unstained cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	prolonged RR interval	J:211773
	thrombocytopenia	J:211773